Szczepienia p-H1N1 u ciężarnych

Od: "NIH OLIB (NIH/OD)"


Do: NIHPRESS@LIST.NIH.GOV

Temat: NIAID LAUNCHES 2009 H1N1 INFLUENZA VACCINE TRIAL IN PREGNANT Women
Data: 9 września 2009 23:04

NIAID LAUNCHES 2009 H1N1 INFLUENZA VACCINE TRIAL IN PREGNANT Women

The first trial testing a candidate 2009 H1N1 influenza vaccine in pregnant
women is launching this week, the National Institute of Allergy and
Infectious Diseases (NIAID), part of the National Institutes of Health, announced
today.

"Women are at higher risk of developing severe illness if they become
infected with influenza virus while pregnant, which is why they are strongly
encouraged to receive the seasonal influenza vaccine every year," says NIAID
Director Anthony S. Fauci, M.D. "Data indicate that pregnant women are at higher
risk for complications from the 2009 H1N1 influenza virus as well, so this
trial will provide critical information for public health planning."

The trial is being conducted through the NIAID-funded national network of
Vaccine and Treatment Evaluation Units (VTEUs).

"The American public has shown once again its remarkable willingness to step
up and help during an emergency. The interest in this trial has been
extraordinary, and participating medical centers expect to fill all the available
slots for volunteers soon," Dr. Fauci adds.

Up to 120 women 18 to 39 years of age who are in their second or third
trimester (14 to 34 weeks) of pregnancy will be enrolled into this initial trial.
Volunteers will receive 15 micrograms or 30 micrograms of a candidate 2009
H1N1 influenza vaccine manufactured by Sanofi Pasteur. All women will receive
an initial injection and a second injection 21 days later. Safety data will be
colle